Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prothena Corp Public (PRTA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to 1666.25%.

  • Prothena Corp Public's EBITDA Margin rose 51907600.0% to 1666.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 2166.42%, marking a year-over-year decrease of 20403000.0%. This contributed to the annual value of 114.36% for FY2024, which is 947200.0% up from last year.
  • According to the latest figures from Q3 2025, Prothena Corp Public's EBITDA Margin is 1666.25%, which was up 51907600.0% from 1914.39% recorded in Q2 2025.
  • In the past 5 years, Prothena Corp Public's EBITDA Margin ranged from a high of 78.48% in Q3 2021 and a low of 163056.0% during Q1 2024
  • Moreover, its 5-year median value for EBITDA Margin was 2596.82% (2023), whereas its average is 12662.11%.
  • In the last 5 years, Prothena Corp Public's EBITDA Margin plummeted by -1604591800bps in 2024 and then soared by 1607370100bps in 2025.
  • Quarter analysis of 5 years shows Prothena Corp Public's EBITDA Margin stood at 2823.55% in 2021, then skyrocketed by 100bps to 0.14% in 2022, then plummeted by -17227855bps to 24846.52% in 2023, then soared by 88bps to 3056.85% in 2024, then soared by 45bps to 1666.25% in 2025.
  • Its EBITDA Margin was 1666.25% in Q3 2025, compared to 1914.39% in Q2 2025 and 2318.99% in Q1 2025.